09 July 2021>: Clinical Research
Secondary Immunodeficiency and Hypogammaglobulinemia with IgG Levels of <5 g/L in Patients with Multiple Myeloma: A Retrospective Study Between 2012 and 2020 at a University Hospital in China
Chunmei Ye 12BCEF* , Weiwei Chen 3EF* , Qi Gao 12B , Yanxia Chen 4B , Xiaolu Song 5B , Sujie Zheng 2C* , Jinlin Liu 2AEG*DOI: 10.12659/MSM.930241
Med Sci Monit 2021; 27:e930241
Table 4 Death rate of multiple myeloma patients with or without secondary immunodeficiency at 1 year and 3 years.
IgG <5 g/L (n=45) | IgG ≥5 g/L (n=103) | |
---|---|---|
Death at 1 year (no./rate) | 15 (33.33) | 13 (12.62) |
Death at 3 years (no./rate) | 23 (51.11) | 24 (23.30) |
All data are presented with no. (%). |